Cancer Genetics and Epigenetics 2024, Vol.12, No.4, 166-181 http://medscipublisher.com/index.php/cge 181 Sharma S., Kelly T.K., and Jones P.A., 2010, Epigenetics in cancer, Carcinogenesis, 31(1): 27-36. https://doi.org/10.1093/carcin/bgp220 Shiovitz S., and Korde L.A., 2015, Genetics of breast cancer: a topic in evolution, Annals of Oncology, 26(7): 1291-1299. https://doi.org/10.1093/annonc/mdv022 Singer C., Balmaña J., Bürki N., Delaloge S., Filieri M., Gerdes A., Grindedal E., Han S., Johansson O., Kaufman B., Krajc M., Loman N., Oláh E., Paluch-Shimon S., Plavetić N., Pohlodek K., Rhiem K., Teixeira M., and Evans D., 2019, Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations, European Journal of Cancer, 106: 54-60. https://doi.org/10.1016/j.ejca.2018.10.007 Sokolova A., Johnstone K., Reed A., Simpson P., and Lakhani S., 2023, Hereditary breast cancer: syndromes, tumour pathology and molecular testing, Histopathology, 82(1): 70-82. https://doi.org/10.1111/his.14808 Surbone A., 2001, Ethical implications of genetic testing for breast cancer susceptibility, Critical Reviews in Oncology/Hematology, 40(2): 149-157. https://doi.org/10.1016/S1040-8428(01)00141-X Suszyńska M., Klonowska K., Jasinska A., and Kozłowski P., 2019, Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes-Providing evidence of cancer predisposition genes, Gynecologic Oncology, 153(2): 452-462. https://doi.org/10.1016/j.ygyno.2019.01.027 Swisher E., Rayes N., Bowen D., Peterson C., Norquist B., Coffin T., Gavin K., Polinsky D., Crase J., Bakkum-Gamez J., Blank S., Munsell M., Nebgen D., Fleming G., Olopade O., Law S., Zhou A., Levine D., D'Andrea A., and Lu K., 2023, Remotely delivered cancer genetic testing in the making genetic testing accessible (MAGENTA) trial: a randomized clinical trial, JAMA Oncology, 9(11): 1547-1555. https://doi.org/10.1001/jamaoncol.2023.3748 Szczepanek J., Skorupa M., Jarkiewicz-Tretyn J., Cybulski C., and Tretyn A., 2023, Harnessing epigenetics for breast cancer therapy: the role of DNA methylation, histone modifications, and MicroRNA, International Journal of Molecular Sciences, 24(8): 7235. https://doi.org/10.3390/ijms24087235 Tamimi F., Sharaf B., Salama O., Edaily S., Khater S., Alkyam M., Abujamous L., Azzam K., Abu-Fares H., Abaza H., and Abdel-Razeq H., 2023, Abstract P6-02-02: challenges and dilemmas following a traceback approach for genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer, Cancer Research, 83(5_Supplement): P6-02. https://doi.org/10.1158/1538-7445.SABCS22-P6-02-02 Thapa S., Leppin A., Kristensen R., Bonde M., and Aro A., 2020, Implementation of interventions targeting the uptake of genetic testing services for breast cancer risk: protocol for a systematic review, BMJ open, 10(6): e031727. https://doi.org/10.1136/bmjopen-2019-031727 Verigos J., and Magklara A., 2015, Revealing the complexity of breast cancer by next generation sequencing, Cancers, 7(4): 2183-2200. https://doi.org/10.3390/cancers7040885 Waarts M.R., Stonestrom A.J., Park Y.C., and Levine R.L., 2022, Targeting mutations in cancer, The Journal of Clinical Investigation, 132(8). https://doi.org/10.1172/JCI154943 Wheler J., Parker B., Lee J., Yelensky R., Moulder S., Tsimberidou A., Janku F., Atkins J., Zinner R., Schwab R., Schwaederlé M., Subbiah V., Fu S., Stephens P., and Kurzrock R., 2013, Abstract A212: next generation sequencing (NGS) in 57 patients with advanced or metastatic breast cancer: identification of unique genomic profiles and correlation with response, Molecular Cancer Therapeutics, 12(11_Supplement): A212. https://doi.org/10.1158/1535-7163.TARG-13-A212 Woodward E., Lalloo F., Forde C., Pugh S., Burghel G., Schlecht H., Harkness E., Howell A., Howell S., Gandhi A., and Evans D., 2024, Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c. 1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400, Journal of Medical Genetics, 61(4): 385-391. https://doi.org/10.1136/jmg-2023-109671 You J.S., and Jones P.A., 2012, Cancer genetics and epigenetics: two sides of the same coin?, Cancer Cell, 22(1): 9-20. https://doi.org/10.1016/j.ccr.2012.06.008
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==